COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE IN COMPARISON TO TRIVALENT INFLUENZA VACCINE IN BRAZIL USING A DYNAMIC MODEL

2017 ◽  
Author(s):  
Pascal Crépey
Keyword(s):  
Cost Effectiveness ◽  
Influenza Vaccine ◽  
Dynamic Model ◽  
Trivalent Influenza Vaccine ◽  
Quadrivalent Influenza Vaccine

scholarly journals PIN60 Cost-Effectiveness of Quadrivalent Influenza Vaccine High Dose Versus Adjuvanted Standard Dose Trivalent Influenza Vaccine in England

2020 ◽  
Vol 23 ◽  
pp. S555
Author(s):  
I. Gibbons ◽  
C. Davidson ◽  
J. Clark-Wright ◽  
C. Miller ◽  
S. Carroll ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Influenza Vaccine ◽  
Standard Dose ◽  
High Dose ◽  
Trivalent Influenza Vaccine ◽  
Quadrivalent Influenza Vaccine

scholarly journals PIN32 Cost-Effectiveness of the CELL-Based Quadrivalent Versus the Standard Egg-Based Quadrivalent Influenza Vaccine in Germany.

2020 ◽  
Vol 23 ◽  
pp. S549
Author(s):  
R. Cai ◽  
M. Eichner ◽  
M. Schwehm ◽  
S. Rajaram ◽  
M.Q. Joaquin F. ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Influenza Vaccine ◽  
Quadrivalent Influenza Vaccine

scholarly journals Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany

2021 ◽  
pp. 1-1
Author(s):  
Rui Cai ◽  
Laetitia Gerlier ◽  
Martin Eichner ◽  
Markus Schwehm ◽  
Sankarasubramanian Rajaram ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Influenza Vaccine ◽  
Quadrivalent Influenza Vaccine

scholarly journals Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina

Vaccine ◽  
2020 ◽  
Vol 38 (20) ◽  
pp. 3682-3689 ◽  
Author(s):  
Van Hung Nguyen ◽  
Carla Vizzotti ◽  
Analia Uruena ◽  
Norberto Giglio ◽  
Cecilia Magneres ◽  
...  
Keyword(s):  
Older Adults ◽  
Cost Effectiveness ◽  
Influenza Vaccine ◽  
Trivalent Influenza Vaccine

scholarly journals Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial

Vaccine ◽  
2014 ◽  
Vol 32 (13) ◽  
pp. 1480-1487 ◽  
Author(s):  
Juan Carlos Tinoco ◽  
Noris Pavia-Ruz ◽  
Aurelio Cruz-Valdez ◽  
Carlos Aranza Doniz ◽  
Vijayalakshmi Chandrasekaran ◽  
...  
Keyword(s):  
Influenza Vaccine ◽  
Randomized Trial ◽  
Vaccine Candidate ◽  
Healthy Adults ◽  
Phase Iii ◽  
Trivalent Influenza Vaccine ◽  
Quadrivalent Influenza Vaccine

scholarly journals Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccine in the United States

2014 ◽  
Vol 17 (7) ◽  
pp. A679
Author(s):  
P.T. De Boer ◽  
R.J. Pitman ◽  
B. Macabeo ◽  
A. Chit ◽  
M.J. Postma ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
Influenza Vaccine ◽  
The United States ◽  
Trivalent Influenza Vaccine

scholarly journals Cost-Effectiveness Analysis of Quadrivalent Influenza Vaccine in Spain

2015 ◽  
Vol 18 (7) ◽  
pp. A588
Author(s):  
A Garcia Rojas ◽  
RL Ortiz de Lejarazu ◽  
J Reina ◽  
D Callejo ◽  
J Cuervo Uría ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Influenza Vaccine ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
Quadrivalent Influenza Vaccine
Sign in / Sign up

Export Citation Format

Share Document